VBIO
Income statement / Annual
Last year (2026), Valion Bio Inc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2026, Valion Bio Inc's net income was -$8.88 M.
See Valion Bio Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2026
|
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$1.18 M |
$1.84 M |
$1.26 M |
$860.00 K |
$420.00 K |
| Cost of Revenue |
$0.00
|
$352.00 K
|
$889.00 K
|
$1.54 M
|
$1.30 M
|
$1.09 M
|
$713.00 K
|
| Gross Profit |
$0.00
|
-$352.00 K
|
$287.00 K
|
$299.00 K
|
-$46.00 K
|
-$233.00 K
|
-$293.00 K
|
| Gross Profit Ratio |
0
|
0
|
0.24
|
0.16
|
-0.04
|
-0.27
|
-0.7
|
| Research and Development Expenses |
$3.13 M
|
$1.31 M
|
$1.66 M
|
$1.73 M
|
$870.00 K
|
$768.00 K
|
$986.00 K
|
| General & Administrative Expenses |
$4.77 M
|
$3.16 M
|
$4.75 M
|
$5.88 M
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$1.19 M
|
$2.13 M
|
$2.79 M
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$4.77 M
|
$2.75 M
|
$6.88 M
|
$8.67 M
|
$4.72 M
|
$2.32 M
|
$2.36 M
|
| Other Expenses |
$0.00
|
-$3.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$7.90 M
|
$4.06 M
|
$8.53 M
|
$10.40 M
|
$5.59 M
|
$3.09 M
|
$3.35 M
|
| Cost And Expenses |
$7.90 M
|
$4.42 M
|
$9.42 M
|
$11.94 M
|
$6.89 M
|
$4.18 M
|
$4.06 M
|
| Interest Income |
$23.00 K
|
$6.00 K
|
$1.00 K
|
$2.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$146.00 K
|
$0.00
|
$0.00
|
$0.00
|
$1.82 M
|
$423.00 K
|
$443.00 K
|
| Depreciation & Amortization |
$5.00 K
|
$352.00 K
|
$182.00 K
|
$174.00 K
|
$24.00 K
|
$8.00 K
|
$4.00 K
|
| EBITDA |
-$7.84 M |
-$4.06 M |
-$8.06 M |
-$9.92 M |
-$5.61 M |
-$3.31 M |
-$3.64 M |
| EBITDA Ratio |
0
|
0
|
-6.86
|
-5.39
|
-4.46
|
-3.85
|
-8.66
|
| Operating Income Ratio |
0
|
0
|
-7.01
|
-5.49
|
-4.48
|
-3.86
|
-8.67
|
| Total Other Income/Expenses Net |
-$95.00 K
|
-$54.00 K
|
$1.00 K
|
$2.00 K
|
-$2.86 M
|
-$318.00 K
|
-$503.00 K
|
| Income Before Tax |
-$7.99 M
|
-$4.47 M
|
-$8.24 M
|
-$10.10 M
|
-$8.49 M
|
-$3.64 M
|
-$4.15 M
|
| Income Before Tax Ratio |
0
|
0
|
-7.01
|
-5.49
|
-6.76
|
-4.23
|
-9.87
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$2.00 K
|
| Net Income |
-$8.88 M
|
-$5.66 M
|
-$8.24 M
|
-$10.10 M
|
-$8.49 M
|
-$3.64 M
|
-$4.15 M
|
| Net Income Ratio |
0
|
0
|
-7.01
|
-5.49
|
-6.76
|
-4.23
|
-9.88
|
| EPS |
-7.84 |
-19.68 |
-176.8 |
-1768 |
-4133.6 |
-667.69 |
-761.09 |
| EPS Diluted |
-7.84 |
-19.68 |
-176.8 |
-1768 |
-4133.6 |
-667.69 |
-761.09 |
| Weighted Average Shares Out |
$1.16 M
|
$287.37 K
|
$46.65 K
|
$5.69 K
|
$2.05 K
|
$5.45 K
|
$5.45 K
|
| Weighted Average Shares Out Diluted |
$1.16 M
|
$287.37 K
|
$46.65 K
|
$5.69 K
|
$2.05 K
|
$5.45 K
|
$5.45 K
|
| Link |
|
|
|
|
|
|
|
